ArticleJournal of community health2025
Feasibility of a Community-Based Youth Focused Opioid Overdose Education and Naloxone Distribution Program.
Article in Journal of community health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Applying the Consolidated Framework for Implementation Research (CFIR) to understand college health administrator perceptions on adopting and implementing opioid overdose education and naloxone distribution (OEND) programs among universities nationally.Harm reduction journal · 2026Article
- Barriers and Facilitators to Naloxone Access for Adolescents: A Narrative Review.Substance use : research and treatmentReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In 2023, there were over 70,000 deaths due to synthetic opioids, which are increasingly being found in all types of illicit drugs, of which 14.7% of youth aged 12-17 years old reported using in the prior year. While several opioid overdose education and naloxone distribution (OEND) programs have emerged, few have focused on the needs of youth. Young HERO, a quality improvement initiative, was developed to provide OEND services specifically to youth and caregivers. The Young HERO initiative consisted of the formation of partnerships with community organizations and the delivery of OEND. Potential organizations were contacted, and if they were interested, a Young HERO event date was set. Partners advertised and hosted the typically one-hour event. After events, attendees were asked to complete a survey assessing their knowledge, confidence, and intervention acceptability. Descriptive statistics were computed. In the first six months, Young HERO events were held, with nine of the initial 13 organizations contacted and two additional events with secondary contacts. A total of 286 individuals received the intervention. The post-event survey was available for 177 individuals, and the overall survey response rate was 77.4% (137). 75% of respondents felt confident that they could administer an opioid overdose reversal medication, and just under 70% strongly recommended the event. In the first six months, Young HERO events were held, with nine of the initial 13 organizations contacted and two additional events with secondary contacts. A total of 286 individuals received the intervention. The post-event survey was available for 177 individuals, and the overall survey response rate was 77.4% (137). 75% of respondents felt confident that they could administer an opioid overdose reversal medication, and just under 70% strongly recommended the event. Young HERO was able to reach youth, young adults, and caregivers to provide both opioid overdose education and naloxone distribution. The initiative offers a model that can be expanded and replicated, supporting efforts to reduce opioid overdose fatalities.
Indexed as
Identifiers
40335866What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.